These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19967945)

  • 1. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are natriuretic peptides a reliable marker for mortality in ESRD patients?
    Locatelli F; Viganò S
    Nephrol Dial Transplant; 2010 Feb; 25(2):347-9. PubMed ID: 19934079
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
    Daly MG; Frampton CM; Troughton RW
    J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 10. B-type natriuretic peptide as a marker of heart failure: Not so specific after all?
    Marshall W; Orlando R
    Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenges of properly identifying the cause of heart failure hospitalization.
    Ghali JK
    Arch Intern Med; 2010 Jul; 170(14):1274-5; author reply 1275. PubMed ID: 20660852
    [No Abstract]   [Full Text] [Related]  

  • 12. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 13. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
    Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
    Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 18. On "Getting the right message".
    Collins SP
    Ann Emerg Med; 2007 Mar; 49(3):383-4; author reply 384. PubMed ID: 17317514
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again.
    Squire I
    Eur Heart J; 2008 Apr; 29(8):959-60. PubMed ID: 18349028
    [No Abstract]   [Full Text] [Related]  

  • 20. Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept?
    Mueller T; Haltmayer M
    Eur Respir J; 2006 Jul; 28(1):7-9. PubMed ID: 16816345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.